Excited state properties such as emission, exciton transport, electron transfer,etc.,are strongly dependent on the shape,sizeand molecular arrangement of chromophore based supramolecular architectures.Herein, we demonstrate creation and control of distinct supramolecular energy landscapes for the reversible control of the excited-state emission processes through cascade energy transfer in chromophore assemblies, facilitated by an unprecedented solvent effect. In methylcyclohexane,atailor-made Y-shaped BODIPY derivative selfassembles to form an unusual spherical architecture of 400-1200 nm size, whichexhibits asingle emission at 540 nm upon 475 nm excitation through an ormal excitation deactivation process.H owever,i nn-decane,t he same BODIPY derivative forms two-dimensional supramolecular sheets,exhibiting multiple emission peaks at 540, 610, 650, 725 and 790 nm with 475 nm excitation due to cascade energy transfer.F urther control on the morphology and excitation energy transfer is possible with variable solvent composition and ultrasound stimulation, resulting in enhanced near-infrared emission with an overall pseudo Stokes shift of 7105 cm À1 .
Excited state properties such as emission, exciton transport, electron transfer, etc., are strongly dependent on the shape, size and molecular arrangement of chromophore based supramolecular architectures. Herein, we demonstrate creation and control of distinct supramolecular energy landscapes for the reversible control of the excited‐state emission processes through cascade energy transfer in chromophore assemblies, facilitated by an unprecedented solvent effect. In methylcyclohexane, a tailor‐made Y‐shaped BODIPY derivative self‐assembles to form an unusual spherical architecture of 400–1200 nm size, which exhibits a single emission at 540 nm upon 475 nm excitation through a normal excitation deactivation process. However, in n‐decane, the same BODIPY derivative forms two‐dimensional supramolecular sheets, exhibiting multiple emission peaks at 540, 610, 650, 725 and 790 nm with 475 nm excitation due to cascade energy transfer. Further control on the morphology and excitation energy transfer is possible with variable solvent composition and ultrasound stimulation, resulting in enhanced near‐infrared emission with an overall pseudo Stokes shift of 7105 cm−1.
One of the bottlenecks associated with supramolecular polymerization of functional pi‐systems is the spontaneous assembly of monomers leading to one‐ or two‐dimensional (1D or 2D) polymers without control over chain length and optical properties. In the case of supramolecular copolymerization of monomers that are structurally too diverse, preferential self‐sorting occurs unless they are closely interacting donor‐acceptor pairs. Herein, we establish that the spontaneous 1D polymerization of a phenyleneethynylene (PE) derivative and the 2D polymerization of a Bodipy derivative (BODIPY) can be controlled by copolymerizing them in different ratios, leading to unusual spindle‐shaped structures with controlled aspect ratio, as evident by scanning electron microscopy (SEM), transmission electron microscopy (TEM) and confocal laser scanning microscopy (CLSM) studies. For example, when the content of BODIPY is 50% in the BODIPY‐PE mixture, the 1D polymerization of PE is significantly restricted to form elongated spindle‐like structures having an aspect ratio of 4‐6. The addition of 75% of BODIPY to PE resulted in circular spindles having an aspect ratio of 1‐2.5, thereby completely restricting the 1D polymerization of PE monomers. Moreover, the resultant supramolecular copolymers exhibited morphology and aspect ratio dependent emission features as observed by the time‐resolved emission studies.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.